CASI Pharmaceuticals Inc (CASI) — Capital Reinvestment Ratio
Latest as of March 2011:
0.01x
CASI Pharmaceuticals Inc (CASI) has a Capital Reinvestment Ratio of 0.01x as of March 2011, meaning it reinvests 0% of its operating cash flow ($462.74K) in capital expenditures ($4.21K). Check how tangible is CASI Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$462.74K
USD
Capital Expenditures
$4.21K
USD
Data as of
Mar 2011
Most recent filing
Annual Capital Reinvestment Ratio for CASI Pharmaceuticals Inc (None–None)
Year-by-year Capital Reinvestment Ratio for CASI Pharmaceuticals Inc from None to None. See CASI Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow